Prelude Capital Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-48,468
| Closed | -$291K | – | 1260 |
|
|
2020
Q4 | $291K | Buy |
48,468
+25,100
| +107% | +$151K | 0.01% | 524 |
|
|
2020
Q3 | $174K | Buy |
+23,368
| New | +$174K | 0.01% | 532 |
|
|
2020
Q1 | – | Sell |
-920
| Closed | -$3K | – | 1275 |
|
|
2019
Q4 | $3K | Sell |
920
-160
| -15% | -$522 | ﹤0.01% | 1323 |
|
|
2019
Q3 | $5K | Sell |
1,080
-25,167
| -96% | -$117K | ﹤0.01% | 1072 |
|
|
2019
Q2 | $323K | Buy |
26,247
+24,735
| +1,636% | +$304K | 0.02% | 351 |
|
|
2019
Q1 | $20K | Sell |
1,512
-1,312
| -46% | -$17.4K | ﹤0.01% | 951 |
|
|
2018
Q4 | $24K | Buy |
2,824
+586
| +26% | +$4.98K | ﹤0.01% | 906 |
|
|
2018
Q3 | $17K | Sell |
2,238
-331
| -13% | -$2.51K | ﹤0.01% | 996 |
|
|
2018
Q2 | $15K | Sell |
2,569
-2,142
| -45% | -$12.5K | ﹤0.01% | 1128 |
|
|
2018
Q1 | $28K | Buy |
4,711
+1,939
| +70% | +$11.5K | ﹤0.01% | 1069 |
|
|
2017
Q4 | $16K | Sell |
2,772
-2,823
| -50% | -$16.3K | ﹤0.01% | 1031 |
|
|
2017
Q3 | $28K | Buy |
5,595
+2,959
| +112% | +$14.8K | ﹤0.01% | 1132 |
|
|
2017
Q2 | $11K | Buy |
+2,636
| New | +$11K | ﹤0.01% | 1260 |
|
|
2016
Q3 | – | Sell |
-1,000
| Closed | -$9K | – | 1637 |
|
|
2016
Q2 | $9K | Buy |
+1,000
| New | +$9K | ﹤0.01% | 1341 |
|